CLOV CLOVER HEALTH INV CORP

Clover Health to Report Second Quarter 2023 Financial Results on August 8, 2023

Clover Health to Report Second Quarter 2023 Financial Results on August 8, 2023

FRANKLIN, Tenn., July 11, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that it will report second quarter 2023 financial results after market close on Tuesday, August 8, 2023. On that day management will host a conference call and webcast at 5:00 p.m. Eastern Time to discuss the Company’s business and financial results.

Second Quarter Conference Call and Webcast Details:

  • What: Clover Health Second Quarter 2023 Earnings Conference Call
  • When: Tuesday, August 8, 2023, at 5:00 p.m. ET
  • Dial In: To access the call via telephone please dial 800-274-8461 (for U.S. callers) or 203-518-9783 (for callers outside the U.S.) and enter the conference ID: CLOVQ223
  • Webcast: A live and archived webcast of the conference call will be accessible from the Investor Relations section of the Company’s website at for 12 months

About Clover Health:

Clover Health (Nasdaq: CLOV) is a physician enablement company committed to bringing access to great healthcare to everyone on Medicare. This includes a health equity-based focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes. We operate two distinct lines of business: Insurance and Non-Insurance. Through our Insurance line of business, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. Our Non-Insurance line of business similarly aims to reduce cost-of-care while enhancing the quality of care for patients enrolled in Original Medicare.

Press Contact:

Andrew Still-Baxter

Investor Relations Contact:

Ryan Schmidt



EN
11/07/2023

Underlying

CLOVCLOVER HEALTH INV CORP

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CLOVER HEALTH INV CORP

 PRESS RELEASE
Free
CLOV CLOVER HEALTH I...

Clover Health Reports Second Quarter 2025 Results; Delivering Strong S...

Clover Health Reports Second Quarter 2025 Results; Delivering Strong Sustainable Growth Second quarter 2025 Medicare Advantage membership of 106,323, up 32% year-over-yearSecond quarter 2025 Total revenues of $478 million, up 34% year-over-yearSecond quarter 2025 profitability metrics with GAAP Net loss of $11 million, Adjusted EBITDA of $17 million, and Adjusted Net income of $17 million Updates Full Year 2025 Guidance: Increases Average Medicare Advantage membership to 104,000 - 108,000, representing 32% growth year-over-year at the midpointMaintains Insurance revenue between $1.800...

August 5, 2025 1 EN
 PRESS RELEASE
Free
CLOV CLOVER HEALTH I...

Primary Care Physician Use of Counterpart Assistant Technology Linked ...

Primary Care Physician Use of Counterpart Assistant Technology Linked to Better Health Outcomes in Patients with Chronic Obstructive Pulmonary Disease New whitepaper shows that a relationship with a primary care physician (“PCP”) who uses Counterpart Assistant is correlated with more frequent Chronic Obstructive Pulmonary Disease (“COPD”) diagnosis, increased specialty care, and meaningful reductions in hospitalizations (15% lower) and 30-day readmissions (18% lower). WILMINGTON, Del., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary o...

August 4, 2025 1 EN
 PRESS RELEASE
Free
CLOV CLOVER HEALTH I...

Clover Health Applauds White House and CMS’ Push to “Tear Down Digital...

Clover Health Applauds White House and CMS’ Push to “Tear Down Digital Walls,” Accelerating and Simplifying Access to Health Data for Patients and Their Clinicians Clover Health’s AI platform, Counterpart Assistant, already connects to a majority of the data networks named in yesterday’s pledge – eliminating the “digital walls,” delivering proven outcomes in chronic disease care, and supporting independent doctors caring for seniors in rural and other underserved areas WILMINGTON, Del., July 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), ...

July 31, 2025 1 EN
 PRESS RELEASE
Free
CLOV CLOVER HEALTH I...

Counterpart Health Appoints Vicky Bruner as Vice President of Operatio...

Counterpart Health Appoints Vicky Bruner as Vice President of Operations to Support Expansion and Customer Execution WILMINGTON, Del., July 29, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI-powered physician-enablement platform, today announced the appointment of Vicky Bruner as Vice President of Operations. As Counterpart scales to meet growing demand from payors and providers nationwide, Bruner will lead several critical functio...

July 29, 2025 1 EN
 PRESS RELEASE
Free
CLOV CLOVER HEALTH I...

Clover Health to Participate in Upcoming Canaccord Genuity 45th Annual...

Clover Health to Participate in Upcoming Canaccord Genuity 45th Annual Growth Conference WILMINGTON, Del., July 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, 2025, at 11:00 a.m. Eastern Time. A live webcast and replay of the presentation will be accessible from Clover Health's investor relations website at . About Clover Health:Clover Health (Nasdaq: CLOV) i...

July 21, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch